Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2036

Annual patent cliff calendar for 2036 — US pharmaceutical patents by expiration date.

Patents
1,428

Quick answer

1,428 indexed pharmaceutical patents have expiration dates in 2036. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 9409905

    Antibacterial compounds and methods for use

    PTC THERAPEUTICS, INC. · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9409884

    5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them

    Rigel Pharmaceuticals, Inc. · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9409880

    Modulators of TLR3/dsRNA complex and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9408901

    Compositions, methods and uses for dengue virus serotype-4 constructs

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9408839

    Antipsychotic treatment based on DRD2 or ANKK1 SNP genotype

    VANDA PHARMACEUTICALS INC. · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9408896

    Vaccination of companion animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9408820

    Broncholytic drug on the basis of prostaglandin

    OBSCHESTVO S OGRANICHENNOY OTVETSTVENNOST'YU “NOXI LAB” · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9408844

    Methods for treating inflammatory conditions

    Melior Discovery, Inc. · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9408813

    Small-molecule inhibitors of dengue virus proteases

    The Board of Regents of the University of Texas System · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9410913

    Methods and systems for measuring and using the oxidation-reduction potential of a biological sample

    Aytu BioScience, Inc. · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9409956

    Salmonella typhi Ty21a expressing Yersinia pestis F1-V fusion protein and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9409944

    Compositions and methods for inhibiting proteases

    The Regents of the University of California · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9409972

    Pharmaceutical composition and method of preparing same

    SAISEI MIRAI CLINIC · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9408829

    Inhibitors of CD40-TRAF6 interaction

    Ludwig-Maximilians-Universitat Munchen · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9408845

    Formulations containing pyridazine compounds

    Northwestern University · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9409662

    Formulations of albu-BChE, preparation and uses thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9410198

    Compostions and methods of nucleic acid-targeting nucleic acids

    Caribou Biosciences, Inc. · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9410154

    HBV treatment

    Benitec Biopharma Limited · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9410969

    Method for determining and treating amyotrophic lateral sclerosis

    China Medical University · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9409992

    Mesothelin domain-specific monoclonal antibodies and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9409965

    Kidney-specific tumor vaccine directed against kidney tumor antigen G-250

    The Regents of the University of California · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9409990

    Methods of inhibiting tumor growth by antagonizing IL-6 receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9409994

    High-affinity monoclonal antibodies to glypican-3 and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9409963

    Fibromodulin peptide

    The Regents of the University of California · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. EP 3053920

    VERBINDUNGEN MIT ANTITUMORAKTIVITÄT

    AB SCIENCE [FR] · Granted Wed Aug 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Aug 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 2016228376

    MONOMETHYLFUMARATE PRODRUG COMPOSITIONS

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Thu Aug 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Aug 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9415098

    DNA vaccine for use in pancreatic cancer patients

    Vaximm AG · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9415116

    Compositions and methods for delivering inhibitory oligonucleotides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9415004

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9416165

    Methods of inhibiting viral replication and improving T cell function employing soluble Tim-3 inhibitors

    The Regents of the University of California · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9415006

    Immunogenic compositions comprising nanoemulsion and hepatitis B virus immunogen and methods of using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9415023

    Compositions comprising terpene compounds for treating negative sensory phenomena

    Board Of Supervisors Of Louisana State University And Agricultural And Mechanical College Pennington Biomedical Research Center · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9415041

    Crystalline freebase forms of a biphenyl compound

    Theravance Biopharma R&D IP, LLC · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9415040

    Inhibition of quorum sensing-mediated processes in bacteria

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9415068

    Method for inhibiting dentinal hypersensitivity

    KURARAY NORITAKE DENTAL INC. · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9415087

    Compositions and methods for treating coronavirus infection

    Ludwig-Maximilians-Universitat Munchen · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9415105

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9416190

    Mesothelin antibodies and methods for eliciting potent antitumor activity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9414599

    Process for the preparation of a metal complex in an oily organic matrix

    Volare & Connecting, LLC · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9416361

    Splice-region antisense composition and method

    Sarepta Therapeutics, Inc. · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9416360

    Base modified oligonucleotides

    MIRAGEN THERAPEUTICS, INC. · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9416167

    Stable liquid formulations of dimer VEGF antagonists

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9416172

    Compositions and methods for treating and preventing Staphylococcus aureus infections

    XBIOTECH INC. · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9416139

    Spiro ring compound as hepatitis C virus (HCV) inhibitor and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9415123

    Polymeric nanoparticles for ultrasound imaging and therapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9416162

    Peptides having reduced toxicity that stimulate cholesterol efflux

    The Regents of the University of California · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9416112

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9415135

    Methods and compositions for stabilizing the myocardium

    The Regents of the University of California · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2036?

1,428 published patents in our USPTO index have expiration dates falling in calendar year 2036.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.